Elephas Reports First Patient Screened for Study
Elephas Biosciences announced today that its first cancer patient was screened at inDNA Life Sciences in India, as part of a study that aims to demonstrate that the Elphas Live…
Elephas Biosciences announced today that its first cancer patient was screened at inDNA Life Sciences in India, as part of a study that aims to demonstrate that the Elphas Live…
Pyran secured additional letters of intent for its 1,5 Pentanediol (1,5 PDO) and expanded its toll manufacturing capabilities to meet growing market demand, the company recently announced. “Our market traction…
Cellectar Biosciences and Evestia Clinical, a leading independent global specialist Contract Research Organization (CRO), have partnered, Cellectar announced recently. According to a release, Evestia will provide Cellectar with full CRO…
NorthStar Medical Radioisotopes and the University of Wisconsin School of Medicine and Public Health have formed a multi-faceted strategic partnership, NorthStar announced today. According to a release, the multi-year partnership…
Immuto Scientific has raised an $8 million Seed 2 financing round, led by DYDX, the company announced recently. According to a release, the funds will be used to advance Immuto…
Cellectar Biosciences and ITM Isotope Technologies Munich SE (ITM) have entered into a supply agreement for Actinium-225 (Ac-225), the companies announced recently. According to a release, the agreement will support…
Exact Sciences announced recently the launch of Cancerguard, a multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States. According to…
Promega has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase, the company announced today. According to a release, the enzyme will enhance Promega’s capabilities…
Imbed Biosciences recently announced the launch of SAM PainGuard with Lidocaine, which encompasses Surgaflex PainGuard for surgical wounds and Pelashield PainGuard for burn and trauma wound management. “Nearly 90% of…
Exact Sciences has entered into an exclusive agreement with Freenome, a biotechnology company pioneering an early cancer detection platform, the company announced recently. According to a release, Exact Sciences will…